Clinical Trial Update: Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate/vilanterol in asthma; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09